The combination of light and chemicals to treat skin diseases is widely pra
cticed in dermatology. Within this broad use of light and drugs, in recent
years the concept of photodynamic therapy (PDT) has emerged. PDT is a promi
sing modality for the management of various tumors and nonmalignant disease
s, based on the combination of a photosensitizer that is selectively locali
zed in the target tissue and illumination of the lesion with visible light,
resulting in photodamage and subsequent cell death. Moreover, the fluoresc
ence of photosensitizing compounds is also utilized as a helpful diagnostic
tool for the detection of neoplastic tissue. Intensive basic and clinical
research culminated in the worldwide approval of PDT for bladder, esophagea
l, and lung cancer. The expanding use of this relatively new therapeutic mo
dality in dermatology at many centers around the world has revealed its eff
icacy for the treatment of cutaneous precancer and cancer, as well as selec
ted benign skin disorders. The following article summarizes the main princi
ples of PDT considering the most recent developments and provides a compreh
ensive synopsis of the present status of the use of PDT in dermatology.